OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmaceuticals is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Antibody–Drug Conjugates: The Last Decade	209
The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs	181
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity	145
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2	108
Towards Better Delivery of Cannabidiol (CBD)	106
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment	106
Lung Fibrosis after COVID-19: Treatment Prospects	105
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside	105
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects	103
Network Pharmacology Approach for Medicinal Plants: Review and Assessment	101
Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review	96
Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery	93
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials	92
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery	91
1,2,4-Triazoles as Important Antibacterial Agents	91
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus	87
Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources	84
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences	83
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications	81
Antibacterials in Aquatic Environment and Their Toxicity to Fish	77
Pharmacological Treatments for Patients with Treatment-Resistant Depression	76
Alginate Nanoformulation: Influence of Process and Selected Variables	75
Mycosporine-Like Amino Acids (MAAs): Biology, Chemistry and Identification Features	75
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth	74
Drug Design by Pharmacophore and Virtual Screening Approach	72

Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells	69
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia	68
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives	68
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review	68
Bone Tissue Engineering in the Treatment of Bone Defects	64
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer	64
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies	62
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme	62
Silica-Based Bioactive Glasses and Their Applications in Hard Tissue Regeneration: A Review	60
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies	59
The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry	58
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies	58
The Chemistry Behind ADCs	58
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug	57
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges	57
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer	56
G-Quadruplexes and Their Ligands: Biophysical Methods to Unravel G-Quadruplex/Ligand Interactions	56
Autophagy as a Potential Therapy for Malignant Glioma	56
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease	55
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release	55
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity	55
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury	54
An Overview of Cellulose Derivatives-Based Dressings for Wound-Healing Management	54
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update	53
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts	53
Periodontal Wound Healing and Tissue Regeneration: A Narrative Review	53
Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview	52